FRESENIUS SE & CO KGAA (FRE.DE) Stock Fundamental Analysis
Europe - FRA:FRE - DE0005785604 - Common Stock
48.72 EUR
-0.31 (-0.63%)
We assign a fundamental rating of 4 out of 10 to FRE. FRE was compared to 31 industry peers in the Health Care Providers & Services industry. While FRE is still in line with the averages on profitability rating, there are concerns on its financial health. While showing a medium growth rate, FRE is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year FRE was profitable.
In the past year FRE had a positive cash flow from operations.
FRE had positive earnings in 4 of the past 5 years.
Each year in the past 5 years FRE had a positive operating cash flow.
1.2 Ratios
With a Return On Assets value of 2.72%, FRE perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
With a Return On Equity value of 6.15%, FRE perfoms like the industry average, outperforming 46.67% of the companies in the same industry.
FRE has a Return On Invested Capital of 3.29%. This is in the lower half of the industry: FRE underperforms 66.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for FRE is below the industry average of 6.75%.
The 3 year average ROIC (1.83%) for FRE is below the current ROIC(3.29%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROIC | 3.29% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
1.3 Margins
FRE has a Profit Margin of 5.06%. This is amongst the best in the industry. FRE outperforms 90.00% of its industry peers.
In the last couple of years the Profit Margin of FRE has declined.
FRE's Operating Margin of 9.96% is amongst the best of the industry. FRE outperforms 90.00% of its industry peers.
In the last couple of years the Operating Margin of FRE has declined.
The Gross Margin of FRE (25.40%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of FRE has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% |
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so FRE is destroying value.
Compared to 1 year ago, FRE has about the same amount of shares outstanding.
The number of shares outstanding for FRE has been increased compared to 5 years ago.
The debt/assets ratio for FRE has been reduced compared to a year ago.
2.2 Solvency
FRE has an Altman-Z score of 2.12. This is not the best score and indicates that FRE is in the grey zone with still only limited risk for bankruptcy at the moment.
FRE has a Altman-Z score (2.12) which is comparable to the rest of the industry.
The Debt to FCF ratio of FRE is 10.07, which is on the high side as it means it would take FRE, 10.07 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 10.07, FRE is in line with its industry, outperforming 50.00% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that FRE is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.61, FRE is doing good in the industry, outperforming 80.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Altman-Z | 2.12 |
ROIC/WACC0.62
WACC5.28%
2.3 Liquidity
A Current Ratio of 1.31 indicates that FRE should not have too much problems paying its short term obligations.
FRE has a Current ratio of 1.31. This is comparable to the rest of the industry: FRE outperforms 60.00% of its industry peers.
FRE has a Quick Ratio of 1.31. This is a bad value and indicates that FRE is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.00, FRE is in line with its industry, outperforming 56.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 |
3. Growth
3.1 Past
FRE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 157.43%, which is quite impressive.
FRE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -2.29% yearly.
The Revenue has been growing slightly by 3.64% in the past year.
Measured over the past years, FRE shows a decrease in Revenue. The Revenue has been decreasing by -9.22% on average per year.
EPS 1Y (TTM)157.43%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-70.97%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%4.05%
3.2 Future
The Earnings Per Share is expected to grow by 10.54% on average over the next years. This is quite good.
FRE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.82% yearly.
EPS Next Y13.43%
EPS Next 2Y12.73%
EPS Next 3Y11.17%
EPS Next 5Y10.54%
Revenue Next Year4.62%
Revenue Next 2Y4.94%
Revenue Next 3Y4.93%
Revenue Next 5Y4.82%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
FRE is valuated rather expensively with a Price/Earnings ratio of 17.53.
The rest of the industry has a similar Price/Earnings ratio as FRE.
The average S&P500 Price/Earnings ratio is at 25.89. FRE is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 12.74, FRE is valued correctly.
FRE's Price/Forward Earnings ratio is in line with the industry average.
FRE's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 34.59.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.53 | ||
| Fwd PE | 12.74 |
4.2 Price Multiples
FRE's Enterprise Value to EBITDA is on the same level as the industry average.
FRE's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. FRE is more expensive than 63.33% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.52 | ||
| EV/EBITDA | 10.63 |
4.3 Compensation for Growth
The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.31
PEG (5Y)N/A
EPS Next 2Y12.73%
EPS Next 3Y11.17%
5. Dividend
5.1 Amount
FRE has a Yearly Dividend Yield of 2.04%. Purely for dividend investing, there may be better candidates out there.
FRE's Dividend Yield is a higher than the industry average which is at 2.44.
Compared to an average S&P500 Dividend Yield of 2.44, FRE has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
5.2 History
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
58.31% of the earnings are spent on dividend by FRE. This is a bit on the high side, but may be sustainable.
DP58.31%
EPS Next 2Y12.73%
EPS Next 3Y11.17%
FRA:FRE (11/14/2025, 7:00:00 PM)
48.72
-0.31 (-0.63%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners44.2%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap27.44B
Revenue(TTM)21.83B
Net Income(TTM)1.13B
Analysts86.09
Price Target52.28 (7.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.04% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP58.31%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.26%
Min EPS beat(2)8.91%
Max EPS beat(2)17.61%
EPS beat(4)3
Avg EPS beat(4)8.92%
Min EPS beat(4)-3.48%
Max EPS beat(4)17.61%
EPS beat(8)4
Avg EPS beat(8)-53.85%
EPS beat(12)6
Avg EPS beat(12)-41.15%
EPS beat(16)8
Avg EPS beat(16)-31.82%
Revenue beat(2)2
Avg Revenue beat(2)2.07%
Min Revenue beat(2)1.31%
Max Revenue beat(2)2.84%
Revenue beat(4)4
Avg Revenue beat(4)1.74%
Min Revenue beat(4)0.41%
Max Revenue beat(4)2.84%
Revenue beat(8)4
Avg Revenue beat(8)0.19%
Revenue beat(12)5
Avg Revenue beat(12)-0.11%
Revenue beat(16)6
Avg Revenue beat(16)0%
PT rev (1m)2.05%
PT rev (3m)5.74%
EPS NQ rev (1m)0.22%
EPS NQ rev (3m)0.66%
EPS NY rev (1m)-0.04%
EPS NY rev (3m)3.03%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)0.05%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.25%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.53 | ||
| Fwd PE | 12.74 | ||
| P/S | 1.23 | ||
| P/FCF | 21.52 | ||
| P/OCF | 12.2 | ||
| P/B | 1.5 | ||
| P/tB | 18.87 | ||
| EV/EBITDA | 10.63 |
EPS(TTM)2.78
EY5.71%
EPS(NY)3.83
Fwd EY7.85%
FCF(TTM)2.26
FCFY4.65%
OCF(TTM)3.99
OCFY8.2%
SpS39.46
BVpS32.46
TBVpS2.58
PEG (NY)1.31
PEG (5Y)N/A
Graham Number45.06
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.72% | ||
| ROE | 6.15% | ||
| ROCE | 6.7% | ||
| ROIC | 3.29% | ||
| ROICexc | 3.6% | ||
| ROICexgc | 7.96% | ||
| OM | 9.96% | ||
| PM (TTM) | 5.06% | ||
| GM | 25.4% | ||
| FCFM | 5.74% |
ROA(3y)0.52%
ROA(5y)1.33%
ROE(3y)2%
ROE(5y)5.13%
ROIC(3y)1.83%
ROIC(5y)2.61%
ROICexc(3y)1.84%
ROICexc(5y)2.65%
ROICexgc(3y)3.69%
ROICexgc(5y)5.83%
ROCE(3y)3.71%
ROCE(5y)5.33%
ROICexgc growth 3Y-17.75%
ROICexgc growth 5Y-15.4%
ROICexc growth 3Y-12.52%
ROICexc growth 5Y-11.09%
OM growth 3Y-9.84%
OM growth 5Y-8.98%
PM growth 3Y-23.64%
PM growth 5Y-16.51%
GM growth 3Y-3.58%
GM growth 5Y-3.36%
F-Score8
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.61 | ||
| Debt/FCF | 10.07 | ||
| Debt/EBITDA | 3.32 | ||
| Cap/Depr | 86.89% | ||
| Cap/Sales | 4.38% | ||
| Interest Coverage | 6.1 | ||
| Cash Conversion | 67.46% | ||
| Profit Quality | 113.33% | ||
| Current Ratio | 1.31 | ||
| Quick Ratio | 1 | ||
| Altman-Z | 2.12 |
F-Score8
WACC5.28%
ROIC/WACC0.62
Cap/Depr(3y)72.62%
Cap/Depr(5y)76.65%
Cap/Sales(3y)6.17%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)157.43%
EPS 3Y-2.62%
EPS 5Y-2.29%
EPS Q2Q%-70.97%
EPS Next Y13.43%
EPS Next 2Y12.73%
EPS Next 3Y11.17%
EPS Next 5Y10.54%
Revenue 1Y (TTM)3.64%
Revenue growth 3Y-16.51%
Revenue growth 5Y-9.22%
Sales Q2Q%4.05%
Revenue Next Year4.62%
Revenue Next 2Y4.94%
Revenue Next 3Y4.93%
Revenue Next 5Y4.82%
EBIT growth 1Y69.58%
EBIT growth 3Y-24.73%
EBIT growth 5Y-17.37%
EBIT Next Year66.43%
EBIT Next 3Y24.05%
EBIT Next 5Y16.35%
FCF growth 1Y-50.31%
FCF growth 3Y-21.04%
FCF growth 5Y-3.73%
OCF growth 1Y-49.36%
OCF growth 3Y-21.94%
OCF growth 5Y-10.74%
FRESENIUS SE & CO KGAA / FRE.DE FAQ
What is the ChartMill fundamental rating of FRESENIUS SE & CO KGAA (FRE.DE) stock?
ChartMill assigns a fundamental rating of 4 / 10 to FRE.DE.
What is the valuation status of FRESENIUS SE & CO KGAA (FRE.DE) stock?
ChartMill assigns a valuation rating of 3 / 10 to FRESENIUS SE & CO KGAA (FRE.DE). This can be considered as Overvalued.
Can you provide the profitability details for FRESENIUS SE & CO KGAA?
FRESENIUS SE & CO KGAA (FRE.DE) has a profitability rating of 5 / 10.
Can you provide the financial health for FRE stock?
The financial health rating of FRESENIUS SE & CO KGAA (FRE.DE) is 4 / 10.
Can you provide the dividend sustainability for FRE stock?
The dividend rating of FRESENIUS SE & CO KGAA (FRE.DE) is 3 / 10 and the dividend payout ratio is 58.31%.